Assorted news from the last two weeks:
NCI unveiled two new resources for young people with cancer:
- tips to help young people facing end-of-life decisions talk with their doctors and make choices about palliative care, advance directives, living wills, and how they want to be remembered.
- resource to help young people find support after a cancer diagnosis and during cancer treatment. It includes advice on talking with mental health experts, spotting signs of depression, and finding support groups.
Study suggests “that children in the U.S. may be treated more intensely compared to children in the U.K., which led to a decreased risk for death from recurrence or progression among childhood cancer survivors, but an increased risk for death due to a health condition likely caused by the cancer treatment among those in the U.S. cohort, such as a second cancer or cardiovascular disease.”
The University of Pittsburgh Graduate School of Public Health will receive a $2.5 million contract from the state of Pennsylvania to study the health effects of hydraulic fracturing, or fracking. In recent years, dozens of cases of Ewing sarcoma, a rare bone cancer, and other childhood and young adult cancers have been identified in Washington, Greene, Fayette and Westmoreland counties, where shale gas sites are operating.
Rhabdomyosarcoma (RMS) is a highly malignant tumor and the most common soft tissue sarcoma in children. In spite of its clinical significance, less is known about genetic susceptibility to this malignancy compared to other pediatric cancers. Researchers at Baylor College of Medicine found that 7.3% of patients with RMS had clinically significant variant changes in cancer-predisposition genes compared to 1.4% of controls.
Upcoming Webinars and Online Opportunities:
- LEARN from recent successes in paediatric oncology drug development worldwide;
- HEAR about the latest regulatory updates in Europe and America;
- DISCUSS in breakout sessions how to accelerate implementation new oncology drug development for children in this new global landscape;
- SHARE advancements in the ACCELERATE program: Paediatric Strategy Forums and Working Groups (FAIR Trials, International Collaboration, Long Term Follow-Up Needs, Fit For Filing) and what is in the pipeline; and
- STRENGTHEN multi-stakeholder international collaboration.